Sharp John P 4
4 · PhaseBio Pharmaceuticals Inc · Filed May 24, 2019
Insider Transaction Report
Form 4
Sharp John P
CFO and Secretary
Transactions
- Exercise/Conversion
Common Stock
2019-05-22$1.69/sh+15,000$25,350→ 20,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-05-22−15,000→ 120,582 totalExercise: $1.69Exp: 2026-05-12→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from March 1, 2016, subject to the reporting person's continued service through each such date.